Intellia Therapeutics Shares Rise 4.8% as FDA Lifts Clinical Hold
Intellia Therapeutics Shares Rise 4.8% as FDA Lifts Clinical Hold
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Intellia Therapeutics Shares Rise 4.8% as FDA Lifts Clinical Hold
SkinBioTherapeutics slashes revenue amid former CEO misconduct probe
SkinBioTherapeutics ex-CEO probe triggers revenue cut, fraud allegations
Plus Therapeutics stock falls after FDA meeting on REYOBIQ trial
Rain crypto has gained 125% over the past 30 days, pushing its market cap to over $2.7B, making it one of Arbitrum's largest coins. This rise follows a spe...
Mercury Bio, a biotechnology company advancing large-molecule therapeutics for neurodegenerative disease, and Meta-Flux, an AI-powered disease simulation c...
Kyverna Therapeutics stock plunges after $100 million share offering
Vyne Therapeutics stock soars after merger with Yarrow Bioscience